Lwimba Kasongo: ‘We Left No Stone Unturned’ – British Haematology Society and UK PACTS Train Local Health Workers
Lwimba Kasongo, Global Patient Advocate and Consultant at The University of Zambia, posted on LinkedIn:
”The British Haematology Society, with the UK PACTS program initiators and London medical Dr’s recently visited Zambia to train health workers on Sickle Cell Disease. This was conducted at two of our largest hospitals in separate provinces. Dr Sahar and Dr Telo were Zambia’s lead training Dr’s.
During the training, a patient panel was selected, Emmanuel and I spoke as SCD patient voices. We were brutally honest about the challenges we face: we left no stone unturned. Being labelled as drug addicts, insensitive comments, lack of urgency when managing our pain, the negligence and neglect in the ER and much more.
The look on their faces, as we spoke told one story, the harsh reality of SCD and how some of their attitudes and lack of knowledge have greatly contributed to increasing the burden of SCD on us.
On the bright side the objective of the training was achieved. Health personnel walked out fully equipped with knowledge on SCD and patient care
I first met the UK PACTS team 3 years ago through Prof. Baba and Dr Chunda – Liyoka. I’m so proud that their work remains truly patient-centered.”
Stay updated with Hemostasis Today.
-
Oct 9, 2025, 19:53Wilfried Dinh: Top 10 Thrombosis And Antithrombotic Therapy Papers Of 2024
-
Oct 9, 2025, 13:12Abdul Mannan - Ferritin After IV Iron: Timing Matters
-
Oct 9, 2025, 13:11William Aird: Understanding the Ferritin Surge After IV Iron
-
Oct 9, 2025, 13:07World Thrombosis Day: The Silent Threat Of Blood Clots Doesn't Discriminate
-
Oct 9, 2025, 13:01Dr. Abigail Amankwa-Boateng Highlights the Hidden Risk of Venous Thromboembolism in Children
-
Oct 10, 2025, 03:09Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
-
Oct 10, 2025, 01:58Emilya Huseynova: Excited to Share That My Work On Blood Safety Monitoring Has Just Been Published by Transfusion
-
Oct 9, 2025, 13:08Superficial Vein Thrombosis: Gregory Piazza Leads JAMA Review Addressing An Underrecognized Challenge
-
Oct 9, 2025, 12:59WFH: Insights From the Prospective Rare Bleeding Disorders Database
-
Oct 9, 2025, 12:58Andrew Jackson: Recurrent Catheter-Related Right Atrial Thrombosis in a Hemodialysis Patient
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
-
Oct 10, 2025, 03:06Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
-
Oct 10, 2025, 03:04Stephen Cornelissen: A New Plasma Drop Has Been Added to Lifeblood’s Blood Supply Tracker
-
Oct 10, 2025, 02:12Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic